Jaguar Health, Inc.
JAGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001585608
No open-market purchases or sales by Jaguar Health, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $15.9K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Jaguar Health, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +5 vs. Q4 2021
- Shares held
- 5.57M
- +998.7K (+21.8%) vs. Q4 2021
- Total value
- $3.94M
- −$809.8K (−17.0%) vs. Q4 2021
- New holders
- 11
- 8 more added
- Sold out
- 6
- 9 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JAGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $15.9K |
| Q1 2026 | 11 | $94.2K |
| Q4 2025 | 11 | $61.4K |
| Q3 2025 | 9 | $222.9K |
| Q2 2025 | 8 | $35.2K |
| Q1 2025 | 8 | $24.6K |
| Q4 2024 | 12 | $283.4K |
| Q3 2024 | 13 | $387.1K |
| Q2 2024 | 12 | $367.0K |
| Q1 2024 | 20 | $523.7K |
| Q4 2023 | 20 | $184.4K |
| Q3 2023 | 14 | $153.2K |
| Q2 2023 | 16 | $231.3K |
| Q1 2023 | 16 | $229.0K |
| Q4 2022 | 30 | $502.9K |
| Q3 2022 | 28 | $873.0K |
| Q2 2022 | 27 | $1.74M |
| Q1 2022 | 33 | $3.94M |
| Q4 2021 | 28 | $4.75M |
| Q3 2021 | 30 | $12.8M |
| Q2 2021 | 36 | $31.9M |
| Q1 2021 | 45 | $13.7M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Jaguar Health, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 1,522,997 | $1.08M | 0.00% | +1,522,997 | New |
| Vanguard Group Inc | 1,075,540 | $762.0K | 0.00% | −770,380−41.7% | Reduced |
| BlackRock Inc. | 765,750 | $543.0K | 0.00% | −5,301−0.7% | Reduced |
| Geode Capital Management, LLC | 380,858 | $269.0K | 0.00% | +11,897+3.2% | Added |
| Virtu Financial LLC | 229,270 | $162.0K | 0.01% | +99,073+76.1% | Added |
| Citadel Advisors LLC | 219,262 | $155.0K | 0.00% | +151,617+224.1% | Added |
| Millennium Management LLC | 211,358 | $150.0K | 0.00% | +211,358 | New |
| Morgan Stanley | 173,090 | $122.0K | 0.00% | +118,189+215.3% | Added |
| Bank of New York Mellon Corp | 169,749 | $120.0K | 0.00% | +141,796+507.3% | Added |
| State Street Corp | 131,838 | $93.0K | 0.00% | 00.0% | Unchanged |
| Principal Financial Group Inc | 113,690 | $81.0K | 0.00% | −55,218−32.7% | Reduced |
| Group One Trading, L.P. | 96,408 | $68.0K | 0.00% | +33,864+54.1% | Added |
| Susquehanna International Group, LLP | 89,638 | $64.0K | 0.00% | −255,513−74.0% | Reduced |
| Northern Trust Corp | 74,699 | $53.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 54,770 | $39.0K | 0.00% | +33,148+153.3% | Added |
| Virtue Capital Management, LLC | 50,000 | $35.0K | 0.01% | +50,000 | New |
| Citigroup Inc | 47,921 | $34.0K | 0.00% | +47,921 | New |
| Jane Street Group, LLC | 33,193 | $23.0K | 0.00% | −79,862−70.6% | Reduced |
| Truist Financial Corp | 29,341 | $21.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 20,829 | $15.0K | 0.00% | −70,985−77.3% | Reduced |
| HRT Financial LP | 18,152 | $12.0K | 0.00% | +18,152 | New |
| Edmond de Rothschild Holding S.A. | 16,666 | $12.0K | 0.00% | +16,666 | New |
| Schonfeld Strategic Advisors LLC | 12,228 | $9.00K | 0.00% | +12,228 | New |
| Two Sigma Securities, LLC | 10,631 | $8.00K | 0.00% | −37,549−77.9% | Reduced |
| Atria Wealth Solutions, Inc. | 10,000 | $7.00K | 0.00% | +10,000 | New |
| Bank of Montreal | 10,181 | $5.00K | 0.00% | +10,181 | New |
| SJS Investment Consulting Inc. | 2,333 | $2.00K | 0.00% | 00.0% | Unchanged |
| WR Wealth Planners, LLC | 250 | $177 | 0.00% | +250 | New |
| Tower Research Capital LLC (TRC) | 95 | $0 | 0.00% | −3,572−97.4% | Reduced |
| Wells Fargo & Company | 270 | $0 | 0.00% | +17+6.7% | Added |
| Stonebridge Capital Advisors LLC | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 33 | $0 | 0.00% | −167−83.5% | Reduced |
| FMR LLC | 166 | $0 | 0.00% | +166 | New |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −167,635−100.0% | Sold out |
| Buckingham Strategic Wealth, LLC | 0 | $0 | 0.00% | −32,000−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −12,413−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −137−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |